期刊文献+

含PGK启动子慢病毒表达质粒的构建与鉴定 被引量:1

Construction and Identification of the Lentiviral Expression Vector With Human PGK Promoters
下载PDF
导出
摘要 为了构建一个含有人源PGK1(human phosphoglycerate kinase 1)启动子的慢病毒表达载体pL-PGK-GFP.采用PCR从人组织中扩增PGK1基因的启动子部分,再用酶切-连接的方法将扩增的启动子区片段亚克隆入慢病毒表达质粒pL-EGFP中,再用测序、酶切和瞬时表达的方法进行鉴定.结果是下游的eGFP基因在PGK1启动子驱动下,在293FT细胞中表达绿色荧光蛋白报告基因,这表明成功构建了慢病毒表达质粒pL-PGK-GFP.扩增的537bp PGK1启动子片段具有一定的启动效率,能在HIV来源的慢病毒载体中驱动下游目的基因的表达. To construct a lentiviral vector pL-PGK-GFP containing the promoter of human phosphoglycerate kinase 1 (PGK1), the promoter fragment of the PGK1 was amplified by PCR from human tissue, then the promoter fragment was subcloned into the lentiviral vector pL-GFP, and was confirmed by double restriction enzyme digestion, sequencing and transiently expressing. The results indicated that the green fluorescence was expressed in 293FT cells by the downstream eGFP gene that was driven by PGK1 promoter, which confirmed that the lentiviral vector pL-PGK-GFP was constructed successfully. The downstream target gene can be driven to express by amplified 537bp PGK1 promoter which promote efficiently in the lentiviral vector of the HIV- based.
出处 《安徽师范大学学报(自然科学版)》 CAS 北大核心 2009年第2期163-167,共5页 Journal of Anhui Normal University(Natural Science)
基金 "十一五"国家科技支撑计划项目(2006BAD04A01 2006BAD04A12) 安徽省自然科学基金(050410201) 安徽省教育厅重点项目(KJ2009A039) 芜湖市科技计划重点项目(2008620)
关键词 PGK启动子 慢病毒载体 基因表达 PGK promoter lentiviral vector gene expression
  • 相关文献

参考文献10

  • 1李振宇,徐开林,潘秀英.慢病毒载体构建及结构优化[J].国外医学(分子生物学分册),2002,24(5):310-313. 被引量:23
  • 2CHALFIE M, TU Y, EUSKIRCHEN G, et al. Green flurescent protein as a marker for genen expression[J]. Science, 1994;263;802 - 805.
  • 3SINGER-Sam J, KEITH DH, TANI K, et al. Sequence of the promoter region of the gene for human X-linked 3-phosphoglycerate kinasel [J]. Gene, 1984,32 (3) :409 - 417.
  • 4SINGER-Sam J, KEITH DH, KENZABURO Tani et al. Sequence of the promoter region of the gene for human X-linled 3-phosphoglycerate kinase[J ]. Gene, 1984,32:409 - 417.
  • 5ALMEIDA L P, ZALA D, AEBISCHER P, et al. Neurop roteetive effect of a CN TF-expressing lentiviral vector in the quinolinic acid rat model of Huntington' s disease[J ]. Neurobioi Dis, 2001,8:433 - 436.
  • 6FLASSHOVE M, BARDENHEUER W, SCHNEIDER A, et al. Type and position of promoter elements in retroviral vectorshave substantial effects on the expression level of an enhanced green fluorescent protein reporter gene[J ]. J Cancer Res Clin Oncol,2000, 126:391 - 399.
  • 7陈香梅,徐开林,潘秀英,李振宇,鹿群先,李德鹏.携带绿色荧光蛋白基因的逆转录病毒载体的构建及其介导的T细胞基因转移研究[J].中国实验血液学杂志,2005,13(4):641-644. 被引量:15
  • 8PAMELA H, CORRELL, SUSAN Colilla, STEFAN Karlsson. Retroviral vector design for long-term expression in murine hematopoietie cells in vivo[J]. Blood, 1994,84(6) : 1812 - 1822.
  • 9RAMEZANI A, HAWLEY TS, HAWLEY RG. Lentiviral vectors for enhanced gene expression in human hematopoietie cells[J]. Molecular Therapy, 2000,2 ( 5 ) : 458 - 469.
  • 10DULL T, ZUFFEREY R, KELLY M, et al. A third-generation lentivirus vector with a conditional packaging system[J]. J Virol, 1998,72 ( 11 ) : 8463 - 8471.

二级参考文献35

  • 1[1]Naldini L et al. Science, 1996;272:263
  • 2[2]Parolin C et al. J Mol Med, 1995; 73:279
  • 3[3]Frankel AD et al. Annu Rev Biochem, 1998;67:1
  • 4[4]Kafri Tet al. Nature Genet,1997;17:314
  • 5[5]Dull T et al. J Virol, 1998;72: 8463
  • 6[6]Xu K Let al. Mol Therapy, 2001;3:97
  • 7[7]Zufferey R et al. Nature Biotechnol, 1997;15:871
  • 8[8]Wu X et al. Mol Therapy, 2000;2:47
  • 9[9]Kotsopoulou E et al. J Virol, 2000;74:4839
  • 10[10]Pandya Set al. Hum Gene Ther, 2001; 12:848

共引文献36

同被引文献26

  • 1吴忠均,陈地龙,石正洪,李德卫,郑树森,时德.人tPA基因真核表达质粒载体构建及其生物学功能研究[J].兰州大学学报(自然科学版),2006,42(2):34-37. 被引量:2
  • 2牛明福,李翔,曹瑞兵,郑其升,魏建超,姬向波,李鹏,周斌,陈溥言.共表达猪繁殖与呼吸综合征病毒GP5基因及猪γ-干扰素基因的腺病毒载体的构建与鉴定[J].中国生物工程杂志,2007,27(1):35-40. 被引量:3
  • 3RAPP J C, HARVEY A J, SPEKSNIJDER G L, et al. Biologically active human interferon α- 2b produced in the egg white of transgenie hens[J]. Transgenie research, 2003,12 : 569 - 575.
  • 4RAJU T S, BRIGGS J B, BORGE S M, et al. Species-specific variation in glycosylation of IgG: evidence for the species-specific sialylation and branch-specific galactosylation and importance for engineering recombinant glycoprotein therapeutics[J]. Glycobiology, 2000,10:477 -486.
  • 5MOZDZIAK P E, BORWORNPINYO S, McCoy D W, et al. Development of transgenic chickens expressing bacterial β-galactosidase[J]. Developmental Dynamics, 2003,226: 439 - 445.
  • 6DULL T, ZUFFEREY R, MANDEL R J, et al. A third generation lentivirus vector with a conditional packaging system[J]. J Viral, 1998, 72:84631.
  • 7LINEOFF A M, TOPOL E J. Illusion of reperfusion. Does anyone achieve optimal reperfusion during dcute myocardial infarction? Circulation, 1993,88(8) : 1361 - 1374.
  • 8ALBERTS M J. tPA in acute ischemic stroke: United States experience and issues for the futute. Neurology, 1998,51 : S53 - S54.
  • 9FAGAN S C, MORGENSTERN L B, A Petitta, et al. Cost-effectiveness of tissue plasminogen activator for acute ischem ic stroke[J]. American Academy Neurology, 1998,50: 883 - 884.
  • 10WEITZ J I, STEWART R, FREDENBUHGR J C. Mechanism of action of plasminogen activators[J]. Thrombosis and Haemostasts, 1999,82 ( 1 ) : 974 - 982.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部